Printer Friendly

ISOMEDIX REPORTS FOURTH QUARTER AND YEAR END RESULTS

 ISOMEDIX REPORTS FOURTH QUARTER AND YEAR END RESULTS
 WHIPPANY, N.J., Feb. 24 /PRNewswire/ -- Isomedix Inc. (NASDAQ: ISMX)


today reported fourth quarter consolidated sales of $7,590,357, exceeding sales of $6,413,534 for the same period in 1990 by 18 percent. Operating income increased 10 percent to $1,849,270 compared with $1,687,884 for the same period last year.
 Consolidated net income in the fourth quarter increased 27 percent to $1,401,640, compared with $1,101,241 earned a year ago. Based on 7,127,532 weighted average number of shares outstanding in the fourth quarter compared with 6,696,775 shares a year ago (a 6 percent increase), earnings per share were 20 cents for the fourth quarter vs. 16 cents for the same period last year, up 25 percent.
 Consolidated sales for the year ended Dec. 31, 1991, were $29,027,383, exceeding sales of $24,659,665 for the same period in 1990 by 18 percent. Operating income increased 30 percent to $8,302,474 compared with $6,375,116 last year.
 Consolidated net income for the year ended Dec. 31, 1991, increased 30 percent to $5,531,096 compared with $4,254,332 earned a year ago. Based on 7,038,817 weighted average number of shares outstanding in 1991 compared with 6,676,825 shares a year ago (a 5 percent increase), earnings per share were 79 cents vs. 64 cents for the same period last year, up 23 percent.
 The company operates a network of nine sterilization facilities in seven states and Canada. The capability to sterilize medical devices with pure ethylene oxide has been added at two of these nine gamma facilities. Isomedix also provides validation services through its Skyland Scientific Services subsidiary located in Montana.
 ISOMEDIX INC.
 Periods ended Three Months Twelve Months
 Dec. 31 1991 1990 1991 1990
 (Unaudited) (Audited)
 Sales $7,590,357 $6,413,534 $29,027,383 $24,659,665
 Operating income 1,849,270 1,687,884 8,302,474 6,375,116
 Net income $1,401,640 $1,101,241 $ 5,531,096 $ 4,254,332
 Earnings per share 20 cents 16 cents 79 cents 64 cents
 Weighted aver. no.
 of shares outstg. 7,127,532 6,696,775 7,038,817 6,676,825
 -0- 2/24/92
 /CONTACT: Thomas J. DeAngelo, vice president-administration and finance of Isomedix, 201-887-4700/
 (ISMX) CO: Isomedix Inc. ST: New Jersey IN: HEA SU: ERN


GK-AH -- NY002 -- 1711 02/24/92 08:30 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 24, 1992
Words:419
Previous Article:EDS REVENUES TOP $7 BILLION FOR FIRST TIME; FOURTH QUARTER BEST IN COMPANY'S HISTORY
Next Article:AAA AND AMERICAN EXPRESS RENEW NO-FEE TRAVELERS CHEQUE AGREEMENT


Related Articles
ISOMEDIX REPORTS RECORD SALES AND OPERATING INCOME FOR THE FIRST QUARTER
ISOMEDIX REPORTS RECORD SECOND QUARTER RESULTS
ISOMEDIX REPORTS RECORD FOURTH QUARTER AND RECORD YEAR END RESULTS; NET INCOME INCREASES 55 PERCENT
ISOMEDIX REPORTS RECORD SALES FOR THE FIRST QUARTER
ISOMEDIX REPORTS SECOND QUARTER RESULTS
ISOMEDIX REPORTS RECORD SALES FOR THE THIRD QUARTER
ISOMEDIX REPORTS RECORD SALES FOR THE FOURTH QUARTER
ISOMEDIX REPORTS YEAR END 1994 RESULTS
ISOMEDIX REPORTS FIRST QUARTER RESULTS
ISOMEDIX REPORTS 1995 YEAR END RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters